Cargando…
Technical Considerations for Use of Oligonucleotide Solution API
The most common approach for the manufacture of oligonucleotides includes isolation of the active pharmaceutical ingredient (API) via lyophilization to provide a solid product, which is then dissolved to provide an aqueous formulation. It is well known from the development and manufacture of large m...
Autores principales: | Muslehiddinoglu, Jale, Simler, Robert, Hill, Malcolm L., Mueller, Claudia, Amery, John H. A., Dixon, Leigh, Watson, Anna, Storch, Kirsten, Gazziola, Cinzia, Gielen, Frank, Lange, Stefan Andreas, Prail, Jeremy D., Nesta, Doug P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415879/ https://www.ncbi.nlm.nih.gov/pubmed/32379529 http://dx.doi.org/10.1089/nat.2020.0846 |
Ejemplares similares
-
Solution Oligonucleotide APIs: Regulatory Considerations
por: Wetter, Christian, et al.
Publicado: (2022) -
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
por: DeCollibus, Daniel Paul, et al.
Publicado: (2023) -
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021) -
Diet quantity influences caste determination in honeybees (Apis mellifera)
por: Slater, Garett P., et al.
Publicado: (2020)